Overview
Luting Luo practices practicing medicine in Quanzhou, China.
Their clinical expertise encompasses Lymphofollicular Hyperplasia, Leukemia, Acute Lymphoblastic Leukemia (ALL), and Angioimmunoblastic T-cell Lymphoma.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Luting T. Luo
Is Luting T. Luo a top-rated expert for Lymphofollicular Hyperplasia?
MediFind is an objective health platform that identifies experts based on real-world data. Luting T. Luo is classified as an Experienced expert for Lymphofollicular Hyperplasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Luting T. Luo participate in research or clinical trials?
Yes. Luting T. Luo has published 12 articles and abstracts on conditions like Lymphofollicular Hyperplasia. You can view a list of Luting T. Luo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Adult T-Cell LeukemiaLuo isExperienced. Learn about Adult T-Cell Leukemia.
- Angioimmunoblastic T-cell Lymphoma
- LeukemiaLuo isExperienced. Learn about Leukemia.
- Lymphofollicular Hyperplasia